Spinal muscular atrophy affects all the body's muscles. For a long time, it was considered a disease caused solely by the loss of nerve cells in the spinal cord. Now, a research team at Leipzig ...

A shaggy, cool-green lichen hangs from the trunk of a tree in a forest on northeastern Vancouver Island, growing on the bark like coral on a rocky sea floor. Lichenologist Trevor Goward has named it ...

While pivotal research on therapies for neovascular age-related macular degeneration (nAMD) and geographic atrophy (GA) focused on one condition or the other, retina specialists commonly encounter ...

A lichen sclerosus diet is a sought-after subject for those with the chronic condition; the hope is that eating or avoiding certain foods may help alleviate symptoms. The condition is not well ...

Risdiplam, an oral pre–messenger RNA splicing modifier, is an efficacious treatment for persons with symptomatic spinal muscular atrophy (SMA). The safety and efficacy of risdiplam in presymptomatic ...

Geographic atrophy (GA) is one of two kinds of advanced age-related macular degeneration (AMD). It’s an eye disease that damages cells in the central part of your retina called the macula. Late-stage ...

Lichen & Limestone, a candle studio and retail shop, is set to open this week in downtown Elizabethtown. The new shop at 101 S. Market St. will be a new production area for owner Gretchen Cobaugh, who ...

Manzitto-Tripp is an associate professor at the University of Colorado Boulder in the Department of Ecology and Evolutionary Biology. She’s also the curator of botany at the school’s Museum of Natural ...

Please provide your email address to receive an email when new articles are posted on . Vulvar lichen sclerosus is likely underdiagnosed in older women, increasing their risk for cutaneous squamous ...

To help shift the country away from its dependence on the United States, Canada’s prime minister plans to spend billions to revitalize its military and meet a NATO spending goal. By Ian Austen ...

Please provide your email address to receive an email when new articles are posted on . Genitourinary syndrome of menopause is common but often underrecognized in dermatology. Low-dose vaginal ...

Compared with placebo, ATH434 demonstrated a statistically significant 48% slowing of clinical progression (based on UMSARS score) at the 50mg dose at week 52. The Food and Drug Administration (FDA) ...